Welireg (belzutifan) — United Healthcare
Pheochromocytoma or paraganglioma (PPGL), advanced, unresectable, or metastatic
Initial criteria
- Diagnosis of pheochromocytoma or paraganglioma (PPGL)
- Disease is one of the following: advanced OR unresectable OR metastatic
Reauthorization criteria
- Patient does not show evidence of disease progression while on Welireg
Approval duration
12 months